Get the Weekly Intelligence Brief — top committee picks every Sunday.

MKC vs UTI

McCormick & Company vs Universal Technical Institute, Inc. — AI-powered side-by-side comparison
MKC
McCormick & Company
63
Buy
VS
UTI
Universal Technical Institute, Inc.
53
Watch
MetricMKCUTI
AI Score 63 53
Price $52.89 $25.56
P/E Ratio 8.79× 40.60×
ROE 13.8% 19.2%
Revenue Growth YoY
Gross Margin 38.6% 61.5%
Debt / Equity 0.71× 1.04×
Dividend Yield 3.6% 0.0%
RSI (14) 65.0 20.6
Beta 0.627 1.236
Expected Upside +31.3%

AI Committee View

Current Innellis committee reasoning for MKC versus UTI.
MKC leads by 10 points.

MKC scores 63/100 (Buy) versus UTI at 53/100 (Watch).

MKC Committee View
67% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — current ratio of 0.70 is tight -- limited short-term liquidity cushion. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • P/E of 8.8 is inexpensive for the broad market — Value
  • ROE of 25.4% shows genuine earnings power backing the valuation — Value
  • Dividend yield of 3.6% pays you to wait — Value
Bear Case
  • Current ratio of 0.70 is tight -- limited short-term liquidity cushion — Risk
UTI Committee View
67% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Technical Analyst remains cautious — rsi at 21 is in oversold territory (could mean either capitulation or a bounce setup). This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Low leverage (debt-to-equity 0.27) -- balance sheet can absorb a shock — Risk
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • P/E of 37.4 is moderate-to-rich — Value
  • Price-to-book of 5.4x prices in significant intangible value — Value
  • EPS declining -25.9% YoY despite any revenue growth — Growth
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
MKC Full Analysis UTI Full Analysis